# Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients

> **NCT05673239** · PHASE4 · COMPLETED · sponsor: **The First Affiliated Hospital of Zhejiang Chinese Medical University** · enrollment: 1008 (actual)

## Conditions studied

- Renal Dialysis

## Interventions

- **DRUG:** Levocarnitine Injection

## Key facts

- **NCT ID:** NCT05673239
- **Lead sponsor:** The First Affiliated Hospital of Zhejiang Chinese Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-15
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 1008 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05673239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05673239, "Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05673239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*